Related Experiment Video

Updated: May 20, 2026

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
07:52

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

Crossing barriers from blood-to-brain and academia-to-industry

Pieter J Gaillard

    Therapeutic Delivery
    |July 27, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease
    06:19

    Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease

    Published on: October 20, 2023

    Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier
    09:10

    Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier

    Published on: January 12, 2024

    Related Experiment Videos

    Last Updated: May 20, 2026

    A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
    07:52

    A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

    Published on: April 9, 2019

    Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease
    06:19

    Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease

    Published on: October 20, 2023

    Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier
    09:10

    Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier

    Published on: January 12, 2024

    Related Concept Videos

    The Blood-brain Barrier00:49

    The Blood-brain Barrier

    Overview
    Crossing Over01:34

    Crossing Over

    Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
    The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process called synapsis.
    In order to...
    Physiological Barriers01:25

    Physiological Barriers

    Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
    The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...

    Articles linked to this work by shared authors, journal, and citation graph.

    Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2019

    In Vivo Quantitative Understanding of PEGylated Liposome's Influence on Brain Delivery of Diphenhydramine.

    Molecular pharmaceutics·2018

    Correction to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017.

    Fluids and barriers of the CNS·2018

    Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017.

    Fluids and barriers of the CNS·2017

    Treatment with penicillin G and hydrocortisone reduces ALS-associated symptoms: a case series of three patients.

    F1000Research·2017

    The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study.

    Journal of pharmaceutical sciences·2017

    Soluble ocular insert of brinzolamide and timolol maleate: in-vitro, ex-vivo and in-vivo characterization.

    Therapeutic delivery·2026

    Aptamer-conjugated curcumin nanomedicine: targeted drug delivery and theranostic innovations in cancer Immunotherapy.

    Therapeutic delivery·2026

    Formulation development and characterization of peptide-based spray-forming in situ gel for enhanced buccal permeation and improved stability.

    Therapeutic delivery·2026

    Formulation and in vitro-in silico characterization of prolonged-release prednisolone acetate spheroids.

    Therapeutic delivery·2026

    Turmeric nanovesicles loaded with vitamins C and E attenuate oxidative stress and improve cognitive outcomes in rats with memory deficits.

    Therapeutic delivery·2026

    Polymeric nanoparticle platforms for ibrutinib delivery: tackling solubility, CYP3A4-mediated metabolism, and resistance to facilitate BTK-targeted therapy in solid tumours.

    Therapeutic delivery·2026

    In situ transformable fibrillar networks ameliorate secondary brain injury after intracerebral hemorrhage by activating KEAP1-Nrf2/ARE axis.

    Biomaterials·2026

    Facile Synthesis of Crystalline Bismuth Nanoparticles Using Orange Peel Extract: Concurrent Antibacterial and Catalytic Efficacy.

    ACS omega·2026

    Antibiofilm Peptides Revisited: From Biofilm Models and Metrics to Mechanisms and Translation.

    ACS infectious diseases·2026

    From Bacterial Cellulose Production by Komagataeibacter xylinus to Bacterial Cellulose Nanoparticles: A Standardized Enzymatic Approach.

    Bio-protocol·2026

    Integrated Algal Biorefineries for Biofuel and Bioplastic Co-Production: Process Performance, Circularity, and Scale-Up.

    Biotechnology and applied biochemistry·2026

    Identification of SpoVID as a putative new substrate of the sporulation-specific protease YabG in Bacillus subtilis.

    Frontiers in microbiology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us